BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 14644724)

  • 1. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
    Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
    Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
    Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
    Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
    Chan WM; Lai TY; Lau TT; Lee VY; Liu DT; Lam DS
    Retina; 2008 Jan; 28(1):71-80. PubMed ID: 18185141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.
    Chan WM; Lam DS; Lai TY; Yuen KS; Liu DT; Chan CK; Chen WQ
    Am J Ophthalmol; 2003 Nov; 136(5):836-45. PubMed ID: 14597034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with multifocal choroiditis.
    Parodi MB; Di Crecchio L; Lanzetta P; Polito A; Bandello F; Ravalico G
    Am J Ophthalmol; 2004 Aug; 138(2):263-9. PubMed ID: 15289136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
    Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
    Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
    Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
    Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
    Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
    Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Arias L; Sanabria MR; Coco R; Silva R; Araiz J; Gomez-Ulla F; Garcia-Layana A
    Acta Ophthalmol Scand; 2006 Dec; 84(6):743-8. PubMed ID: 17083531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study.
    Costa RA; Williams GA;
    Retina; 2006 Sep; 26(7):757-64. PubMed ID: 16963848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.